30y+ of passion for Market Access.
And counting.
With you.
This is us.
Experience
10y+ across the full health system: statutory and private health insurance first, then pharma and biotech consulting. Full HTA landscape — AMNOG and early benefit assessment, JCAs under EU-HTA, real-world evidence design, indirect comparisons, outcomes research. Thinks in integrated strategies — connecting evidence with regulatory and payer requirements, from early development to market access.
Education
B.A. Health Economics, then Health Care Management and Health Economics at Universität Hamburg.
At VIVASIO
Leads Real World Evidence & HTA Strategy. Building, positioning, and using the right evidence — for sustainable patient access.
Off the RWE tour
People. Bringing them together, keeping them together, making sure no one gets left behind. As Volunteer Coordinator at Kinderklinikkonzerte e.V., Stephanie leads the team on tour. Live music for children in hospitals — logistics, empathy, and someone who genuinely cares.
Experience
8y+ across the German healthcare system: health insurance first, then pharmaceutical market access and HTA consulting.
Deep expertise in HTA across national and European frameworks, spanning AMNOG and Joint Clinical Assessments. Always looking beyond the assessment itself, connecting HTA with value demonstration, payer expectations and pricing implications.
Education
B.A. Business & Health Economics and M.Sc. Medical Process Management at FAU Erlangen-Nürnberg.
At VIVASIO
Leads HTA & Value Strategy. Shaping HTA strategies that strengthen value perception, payer positioning and pricing outcomes.
Off the HTA court
Handball. Pivot player, defensive specialist and former coach. Creating space where others see barriers, holding the line when it matters and knowing that the best results come from trust, teamwork and the right move at the right time.
Experience
10y+ in Market Access: Germany and Europe. AMNOG end to end: From evidence strategy to HTA dossiers to price negotiations. RWE from idea to impact. National and European launch experience from strategy to execution.
Before consulting: Market Access at a top-20 pharma, regulation at German Federal Ministry of Health.
Education and research
TU Berlin, KTH Stockholm, UC Berkeley.
At VIVASIO
Strategy and operations alongside client work — never detached from it. Concept and development of VIVASIO Lucus, our AI suite.
Off the strategy deep dives
Wildlife. Underwater or in the bush — always striving to get a crisp picture of what's ahead.
Experience
10y+ in Market Access: top-10 pharma first, in consulting since 2018. Pricing strategy and negotiations. Cross-sector reimbursement. Evidence designed for payer expectations and the political framework. Driven by tight cross-functional alignment — so good products actually reach patients.
Education
B.A. International Business Administration, then MBA & Engineering in Life Science Management. Both in Berlin.
At VIVASIO
Leads Pricing & Access Strategy — from early price corridors to closed deals. Sustainable patient access and commercial viability.
Off the pricing trail
Mountains. Running. Lots of running. Climbing and snowboarding when the mood strikes. And when no mountain is close — board games. The strategic ones.
Our Company is New.
Our Team is Not.
New on paper. Seasoned in practice.
We've been doing this for years - long enough to know what works, and still young enough to keep it exciting. We bring both expertise and agility to the table. So while the company is fresh, it's backed by experience.
And passion.
Our team's combined expertise
30+
Years
of combined experience
50+
Indications
from ultra-orphan to primary care
50+
Products
supported on their way to patients
250+
Projects
from early strategy to full launch execution